Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 October, 2018 10:24 IST
Cipla, Unitaid enter into landmark deal to lower price of HIV drug
Source: IRIS | 08 Jun, 2018, 05.07PM
Comments  |  Post Comment

Unitaid and Indian drug manufacturer Cipla struck a landmark agreement today that will lower the price of the first combination therapy (containing co-trimoxazole, isoniazid and vitamin B6) that prevents opportunistic infections in people living with HIV.

The HIV virus can weaken the immune system, increasing the risk of dangerous infection by bacteria and viruses.

Under this agreement, Cipla will reduce the ceiling price of the medicine by more than 30 percent from USD 3 to USD 1.99 per person, per month, for all public-sector procurers in low- and middle-income countries. The price of the product is expected to come down more as governments and international funding bodies procure larger quantities for their HIV treatment programmes.

Shares of the company gained Rs 18, or 3.33%, to settle at Rs 558.25. The total volume of shares traded was 204,043 at the BSE (Friday).





Cipla Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Glenmark Pharma to present data on investigational treatment for Atopic Dermatitis - 19-Oct-2018 09:55
Zydus receives tentative approval from USFDA for Colchicine Tablets - 18-Oct-2018 16:21
Ramco Systems partners with Airbus Helicopters SAS - 18-Oct-2018 10:26
ABB bags transformer order worth Rs 1.15 bn from Indian Railways - 18-Oct-2018 10:20
Zydus Cadila gets nod for Clobetasol propionate cream - 17-Oct-2018 15:19
Aurionpro Solutions to acquire majority stake in Singapore based SC Soft - 17-Oct-2018 13:26
Adani Group partners with Total to provide multi-energy offering - 17-Oct-2018 13:16
Sterlite Tech wins Rs 35 bn contract for Indian Navy's digital network - 16-Oct-2018 11:03
Lupin receives tentative approval for generic Lurasidone HCl tablets - 16-Oct-2018 09:42
Glenmark Pharma gets nod for Hydrocortisone Valerate cream - 16-Oct-2018 09:25
Shriram Transport to raise upto Rs 13.50 bn via NCDs - 15-Oct-2018 10:29
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer